Utilization of achiral alkenyl amines for the preparation of high affinity Grb2 SH2 domain-binding macrocycles by ring-closing metathesis

被引:7
作者
Liu, Fa
Worthy, Karen M.
Bindu, Lakshman
Giubellino, Alessio
Bottaro, Donald P.
Fisher, Robert J.
Burke, Terrence R., Jr.
机构
[1] NCI Frederick, Ctr Canc Res, Med Chem Lab, Frederick, MD 21702 USA
[2] SAIC Frederick, Prot Chem Lab, Frederick, MD 21702 USA
[3] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20989 USA
关键词
D O I
10.1039/b611887a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A family of previously reported ring-closing metathesis (RCM)-derived macrocycles that exhibit potent Grb2 SH2 domain-binding affinity is characterized by stereoselectively-introduced upper ring junctions that bear bicyclic aryl substituents. However, the synthetic complexity of these macrocycles presents a potential limit to their therapeutic application. Therefore, the current study was undertaken to simplify these macrocycles through the use of achiral 4-pentenylamides as ring-forming components. A series of macrocycles (5a - f) was prepared bearing both open and cyclic constructs at the upper ring junction. The Grb2 SH2 domain-binding affinities of these macrocycles varied, with higher affinities being obtained with cyclo-substituents. The most potent analogue (5d) contained a cyclohexyl group and exhibited Grb2 SH2 domain-binding affinity (K-D = 1.3 nM) that was nearly equal to the parent macrocycle ( 2), which bore a stereoselectively-introduced naphthylmethyl substituent at the upper ring junction (K-D = 0.9 nM). The results of this study advance design considerations that should facilitate the development of Grb2 SH2 domain-binding antagonists.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 32 条
[1]   Role of tyrosine kinase inhibitors in cancer therapy [J].
Arora, A ;
Scholar, EM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :971-979
[2]   Platinum-catalyzed intramolecular hydroamination of unactivated olefins with secondary alkylamines [J].
Bender, CF ;
Widenhoefer, RA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (04) :1070-1071
[3]   Development of Grb2 SH2 domain signaling antagonists: A potential new class of antiproliferative agents [J].
Burke, TR .
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2006, 12 (01) :33-48
[4]   1-HYDROXY-7-AZABENZOTRIAZOLE - AN EFFICIENT PEPTIDE COUPLING ADDITIVE [J].
CARPINO, LA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (10) :4397-4398
[5]   DIE SYNCHRONE FRAGMENTIERUNG VON GAMMA-AMINO-CYCLOALKYLHALOGENIDEN .3. 4-CHLORPIPERIDINE [J].
DARCY, R ;
GROB, CA ;
KAFFENBE.T ;
KRASNOBA.V .
HELVETICA CHIMICA ACTA, 1966, 49 :185-&
[6]   Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy [J].
Dharmawardana, PG ;
Peruzzi, B ;
Giubellino, A ;
Burke, TR ;
Bottaro, DP .
ANTI-CANCER DRUGS, 2006, 17 (01) :13-20
[7]   Metalated nitriles:: Halogen-metal exchange with α-halonitriles [J].
Fleming, FF ;
Zhang, ZY ;
Knochel, P .
ORGANIC LETTERS, 2004, 6 (04) :501-503
[8]   Structure-based design and synthesis of nigh affinity tripeptide ligands of the Grb2-SH2 domain [J].
Furet, P ;
Gay, B ;
Caravatti, G ;
García-Echeverría, C ;
Rahuel, J ;
Schoepfer, J ;
Fretz, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3442-3449
[9]   Olefin metathesis in the design and synthesis of a globally constrained Grb2 SH2 domain inhibitor [J].
Gao, Y ;
Wei, CQ ;
Burke, TR .
ORGANIC LETTERS, 2001, 3 (11) :1617-1620
[10]   Mapping the X+1 binding site of the Grb2-SH2 domain with α,α-disubstituted cyclic α-amino acids [J].
García-Echeverría, C ;
Gay, B ;
Rahuel, J ;
Furet, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (20) :2915-2920